Facial skin barrier function recovery after microneedle transdermal delivery treatment

Dermatologic Surgery

Volumn 38, Issue 11, 2012, Pages 1816-1822

  Han, Tae Y ^a   Park, Kui Y ^b   Ahn, Ji Y ^c   Kim, Seo W ^a   Jung, Hye J ^c   Kim, Beom J ^b  

^a Eulji General Hospital   (South Korea)

^b National Medical Center   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DRUG DELIVERY SYSTEM; ELECTRIC CAPACITANCE; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDRATION; MALE; MICRONEEDLE; PERMEABILITY BARRIER; PRIORITY JOURNAL; SKIN CONDUCTANCE; SKIN DEFECT; SKIN PERMEABILITY; SKIN WATER LOSS; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; DRUG DELIVERY SYSTEMS; FACE; FEMALE; HUMANS; MALE; MICROINJECTIONS; NEEDLES; SKIN PHYSIOLOGICAL PROCESSES; WATER LOSS, INSENSIBLE; YOUNG ADULT;

EID: 84868192649     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2012.02550.x     Document Type: Article

References (28)

1. Bal SM, Caussin J, Pavel S, Bouwstra JA,. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 2008; 35: 193-202.
2. Wermeling DP, Banks SL, Hudson DA, Gill HS, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A 2008; 105: 2058-63.
3. Guy RH, Kalia YN, Delgado-Charro MB, Merino V, et al. Iontophoresis: electrorepulsion and electroosmosis. J Control Release 2000; 64: 129-32.
4. Kalia YN, Naik A, Garrison J, Guy RH,. Iontophoretic drug delivery. Adv Drug Deliv Rev 2004; 56: 619-58.
5. Lee JW, Park JH, Prausnitz MR,. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008; 29: 2113-4.
6. Mitragotri S, Blankschtein D, Langer R,. Ultrasound-mediated transdermal protein delivery. Science 1995; 269: 850-3.
7. Paliwal S, Mitragotri S,. Ultrasound-induced cavitation: applications in drug and gene delivery. Expert Opin Drug Deliv 2006; 3: 713-26.
8. Prausnitz MR,. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004; 56: 581-7.
9. Prausnitz MR, Bose VG, Langer R, Weaver JC,. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A 1993; 90: 10504-8.
10. Vemulapalli V, Yang Y, Friden PM, Banga AK,. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J Pharm Pharmacol 2008; 60: 27-33.
11. Banga AK,. Transdermal and intradermal delivery of therapeutic agents: application of physical technologies. Boca Raton: CRC, 2011.
12. Kalluri H, Kolli CS, Banga AK,. Characterization of microchannels created by metal microneedles: formation and closure. AAPS J 2011; 13: 473-81.
13. Kaushik S, Hord AH, Denson DD, McAllister DV, et al. Lack of pain associated with microfabricated microneedles. Anesth Analg 2001; 92: 502-4.
14. Haq MI, Smith E, John DN, Kalavala M, et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 2009; 11: 35-47.
15. Donnelly RF, Singh TR, Tunney MM, Morrow DI, et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res 2009; 26: 2513-22.
16. Doddaballapur S,. Microneedling with dermaroller. J Cutan Aesthet Surg 2009; 2: 110-1.
17. Majid I,. Microneedling therapy in atrophic facial scars: an objective assessment. J Cutan Aesthet Surg 2009; 2: 26-30.
18. Fabbrocini G, Fardella N, Monfrecola A, Proietti I, et al. Acne scarring treatment using skin needling. Clin Exp Dermatol 2009; 34: 874-9.
19. Leheta T, El Tawdy A, Abdel Hay R, Farid S,. Percutaneous collagen induction versus full-concentration trichloroacetic acid in the treatment of atrophic scars. Dermatol Surg 2011; 37: 207-16.
20. Fernandes D,. Minimally invasive percutaneous collagen induction. Oral Maxillofac Surg Clin North Am 2005; 17: 51-63.
21. Fluhr JW, Dickel H, Kuss O, Weyher I, et al. Impact of anatomical locatoion on barrier recovery, surface pH and stratum corneum hydration after acute barrier disruption. Br J Dermatol 2002; 146: 770-6.
22. Köck A, Schwarz T, Kirnbauer R, Urbanski A, et al. Human keratinocytes are a source for tumor-necrosis-factor-alpha:evidence for synthesis and release upon stimulation with endotoxin or ultraviolet-light. J Exp Med 1990; 172: 1609-14.
23. Wood LC, Jackson SM, Elias PM, Grunfeld C, et al. Cutaneous barrier pertubation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90: 482-7.
24. Corsini E, Galli CL,. Epidermal cytokines in experimental contact dermatitis. Toxicology 2000; 142: 203-11.
25. Bauer D, Grebe R, Ehrlacher A,. A new method to model change in cutaneous blood flow due to mechanical skin irriation. J Theor Biol 2006; 238: 575-87.
26. De Jongh CM, Verberk MM, Withagen CE, Jacobs JJ, et al. Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis 2006; 54: 325-33.
27. Schwarz T, Luger TA,. Effect of UV irradiation on epidermal cell cytokines production. J Photochem Photobiol, B 1989; 4: 1-13.
28. Fluhr JW, Akengin A, Bornkessel A, Fuchs S, et al. Addictive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo. Br J Dermatol 2005; 153: 125-31.